Swedish Orphan Biovitrum AB (publ) KOL Event Call Transcript
Ladies and gentlemen, welcome to the Sobi KOL Investor Event, the journey for Vonjo Conference Call and live webcast. I am Alice, the Chorus Call operator. (Operator Instructions) The conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.
()-&
Yes. Thank you so much, and welcome to this conference, which is dedicated to Vonjo. Before we start, I would like to provide you with some forward-looking statement as per usual, and let's go straight to the next slide. And today, it's really about Vonjo, pacritinib, our recent acquisition that we got going with CTI. And as we discussed yesterday in our earnings call, we wanted to provide you with some more information on Vonjo. And basically, today, I'm really blessed to be (inaudible) by
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |